Valuation: PharmaEssentia Corporation

Market Cap 468B 14.46B 12.7B 11.81B 10.84B 20.37B 1,393B 20.68B 140B 54.81B 685B 54.3B 53.13B 2,368B P/E 2026 *
43.6x
P/E 2027 * 31.7x
Enterprise Value 441B 13.64B 11.98B 11.14B 10.23B 19.21B 1,314B 19.51B 132B 51.7B 646B 51.22B 50.11B 2,233B EV / Sales 2026 *
17.6x
EV / Sales 2027 * 12.5x
Free-Float
75.37%
Yield 2026 *
0.08%
Yield 2027 * 0.13%
1 day-1.30%
1 week-9.92%
Current month-6.04%
1 month+14.98%
3 months+100.16%
6 months+109.84%
Current year+167.88%
1 week 1,120
Extreme 1120
1,235
1 month 1,032.2
Extreme 1032.2031
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 01/09/2003
Director/Board Member - -
Director/Board Member - 30/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
-1.30%-9.92%+160.67%+284.37% 14.64B
-1.92%-1.57%+48.70%+84.37% 55.92B
+0.93%+7.22%+64.67%+63.56% 56.67B
-2.97%-2.35%-22.03%-16.54% 23.28B
-0.46%-1.29%+3.28%+422.58% 23.28B
-0.36%-0.56%+36.00%-3.93% 20.54B
-1.34%-0.63%+29.60%-32.53% 17.78B
-1.44%-1.63%+37.07%+589.93% 15.9B
-0.50%-0.98%+23.62%+178.38% 13.99B
-1.36%+15.21%+426.45%+144.15% 12.22B
Average -0.99%+2.58%+80.80%+171.44% 25.42B
Weighted average by Cap. -0.83%+2.44%+61.77%+137.33%

Financials

2026 *2027 *
Net sales 25.07B 775M 681M 633M 581M 1.09B 74.62B 1.11B 7.52B 2.94B 36.69B 2.91B 2.85B 127B 34.57B 1.07B 938M 873M 801M 1.5B 103B 1.53B 10.36B 4.05B 50.59B 4.01B 3.92B 175B
Net income 10.85B 336M 295M 274M 251M 473M 32.31B 480M 3.25B 1.27B 15.89B 1.26B 1.23B 54.92B 14.97B 463M 406M 378M 347M 652M 44.57B 662M 4.49B 1.75B 21.91B 1.74B 1.7B 75.76B
Net Debt -26.52B -820M -720M -670M -615M -1.15B -78.96B -1.17B -7.95B -3.11B -38.82B -3.08B -3.01B -134B -34.73B -1.07B -943M -877M -805M -1.51B -103B -1.54B -10.41B -4.07B -50.82B -4.03B -3.94B -176B
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
24/07/26 NT$1,135.00 -1.30% 1,580,118
23/07/26 NT$1,150.00 -2.54% 2,928,191
22/07/26 NT$1,180.00 +0.43% 2,030,357
21/07/26 NT$1,175.00 0.00% 2,044,851
20/07/26 NT$1,175.00 -1.67% 2,926,691
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,135.00TWD
Average target price
1,073.31TWD
Spread / Average Target
-5.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock